Literature DB >> 34183033

Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.

Maria Chiara De Nardo1, Anna Rita Bellomo2, Francesca Perfetti2, Francesco Antonino Battaglia3, Miriam Lichtner4, Riccardo Lubrano2.   

Abstract

BACKGROUND: Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. CASE
PRESENTATION: We report a case of the joint management of a healthy neonate with his mother tested positive for Covid-19 before the delivery and throughout neonatal follow-up. The infection transmission from the mother to her baby is not described, even after a long period of contact between them and breastfeeding.
CONCLUSION: It may consider an appropriate practice to keep mother and her newborn infant together in order to facilitate their contact and to encourage breastfeeding, although integration with infection prevention measures is needed.

Entities:  

Keywords:  Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission

Year:  2021        PMID: 34183033     DOI: 10.1186/s12985-021-01598-w

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  1 in total

1.  In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018.

Authors:  Qiwen Yang; Hui Zhang; Yunsong Yu; Haishen Kong; Qiong Duan; Yong Wang; Shufang Zhang; Ziyong Sun; Kang Liao; Li Gu; Xiaofeng Jiang; Anhua Wu; Wenxiang Huang; Bin Shan; Mei Kang; Fupin Hu; Hua Yu; Weijuan Zhang; Yingchun Xu
Journal:  Clin Infect Dis       Date:  2020-12-23       Impact factor: 9.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.